NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Guidance for the First Half of Fiscal 2024 and the Full Year Ending March 31, 2024
April 28, 2023 at 02:00 am EDT
Share
NIHON CHOUZAI Co.,Ltd. provided consolidated earnings guidance for the first half of fiscal 2024 and the full year ending March 31, 2024. For the first half, the company expects net sales of ¥164,100 million, an Operating profit of ¥1,400 million; Profit attributable to owners of the parent of ¥400 million or ¥13.37 per share.
For the year ending March 31, 2024, the company expects net sales of ¥334,400 million, an Operating profit of ¥6,400 million; Profit attributable to owners of the parent of ¥3,200 million or ¥106.97 per share.
NIHON CHOUZAI Co., Ltd is primarily engaged in the pharmacy business, the provision of staffing services, as well as the manufacture and sale of pharmaceutical products. The Company operates in three business segments. The Pharmacy segment is engaged in the operation of a chain of dispensing pharmacies. The Pharmaceutical Product Manufacturing and Distribution segment is engaged in the manufacture and nationwide sale of generic pharmaceutical products. The Healthcare Personnel Staffing Service segment is involved in the dispatching of pharmacists to various regional pharmacies.